Dr. Brittney J. Schultz
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 282
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: University of Minnesota Medical School
- 2014Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
MN license 61357
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- M Health Fairview University of Mn Medical Center Minneapolis, MN
Medical groups
- Fairview Express Care (1,911 clinicians)
- University of Minnesota Health Clinics and Surgery Center Inc (617 clinicians)
- Fairview Specialty Services (306 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 282
- Services billed
- 1,433
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 211 | 49 |
| Established patient office or other outpatient visit, 30-39 minutes | 176 | 106 |
| Established patient office or other outpatient visit, 20-29 minutes | 138 | 111 |
| Biopsy of related skin growth, first growth | 114 | 97 |
| Destruction of precancer skin growth, 1 growth | 99 | 76 |
| Biopsy of related skin growth, each additional growth | 90 | 48 |
| Application of ultraviolet light to skin | 62 | 12 |
| Destruction of skin growth, 1-14 growths | 60 | 47 |
| New patient office or other outpatient visit, 30-44 minutes | 17 | 17 |
| New patient office or other outpatient visit, 45-59 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 49 payments worth $43,403 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $22,988 |
|---|---|
| Regeneron Pharmaceuticals, Inc. | $13,079 |
| Biocryst Pharmaceuticals, Inc. | $3,721 |
| Genzyme Corporation | $3,615 |
| Consulting Fee | $38,690 |
|---|---|
| Travel and Lodging | $3,881 |
| Food and Beverage | $831 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $6,405 |
| Regeneron Healthcare Solutions, Inc. Aug 8, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,978 |
| Regeneron Healthcare Solutions, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,978 |
| Regeneron Healthcare Solutions, Inc. Aug 8, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,124 |
| Genzyme Corporation Oct 30, 2025 | Consulting Fee DUPIXENT · Immunology | $3,615 |
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,416 |
| Regeneron Healthcare Solutions, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,416 |
| Biocryst Pharmaceuticals, Inc. Nov 19, 2025 | Consulting Fee | $3,050 |
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,708 |
| Regeneron Healthcare Solutions, Inc. Mar 18, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CORAL GABLES, FL · in-kind | $601 |
All 31 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Biocryst Pharmaceuticals, Inc. Nov 19, 2025 | Consulting Fee | $3,050 |
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $6,405 |
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,416 |
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,708 |
| Regeneron Pharmaceuticals, Inc. Nov 7, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $39.07 |
| Genzyme Corporation Oct 30, 2025 | Consulting Fee DUPIXENT · Immunology | $3,615 |
| Regeneron Pharmaceuticals, Inc. Oct 17, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $186 |
| Regeneron Pharmaceuticals, Inc. Oct 17, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $186 |
| Regeneron Pharmaceuticals, Inc. Oct 13, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $292 |
| Regeneron Healthcare Solutions, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,978 |
| Regeneron Healthcare Solutions, Inc. Oct 10, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,416 |
| Regeneron Healthcare Solutions, Inc. Oct 10, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ROSEMONT, IL · in-kind | $35.81 |
| Regeneron Healthcare Solutions, Inc. Oct 10, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ROSEMONT, IL · in-kind | $16.80 |
| Regeneron Pharmaceuticals, Inc. Sep 15, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $224 |
| Regeneron Pharmaceuticals, Inc. Sep 15, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $203 |
| Regeneron Pharmaceuticals, Inc. Sep 15, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $35.25 |
| Regeneron Pharmaceuticals, Inc. Sep 15, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CHICAGO, IL · in-kind | $35.25 |
| Biocryst Pharmaceuticals, Inc. Sep 8, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $164 |
| Biocryst Pharmaceuticals, Inc. Sep 8, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $29.00 |
| Regeneron Healthcare Solutions, Inc. Aug 26, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ROSEMONT, IL · in-kind | $193 |
| Biocryst Pharmaceuticals, Inc. Aug 15, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $449 |
| Biocryst Pharmaceuticals, Inc. Aug 15, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $29.00 |
| Regeneron Healthcare Solutions, Inc. Aug 8, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,978 |
| Regeneron Healthcare Solutions, Inc. Aug 8, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $5,124 |
| Regeneron Healthcare Solutions, Inc. Aug 8, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CORAL GABLES, FL · in-kind | $58.60 |
| Regeneron Healthcare Solutions, Inc. Jul 16, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ROSEMONT, IL · in-kind | $407 |
| Regeneron Healthcare Solutions, Inc. Jul 16, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to ROSEMONT, IL · in-kind | $35.25 |
| Regeneron Healthcare Solutions, Inc. Mar 25, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CORAL GABLES, FL · in-kind | $198 |
| Regeneron Healthcare Solutions, Inc. Mar 24, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CORAL GABLES, FL · in-kind | $428 |
| Regeneron Healthcare Solutions, Inc. Mar 18, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CORAL GABLES, FL · in-kind | $601 |
| Regeneron Healthcare Solutions, Inc. Mar 18, 2025 | Travel and Lodging DUPIXENT · IMMUNOLOGY AND INFLAMMATION · travel to CORAL GABLES, FL · in-kind | $35.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,005 in research payments for these studies, mostly to the institutions running them.
- A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)
UCB SA · Completed · NCT05277571
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.